Gecko acquired by Teva Pharmaceuticals (NYSE:TEVA) in September 2015. (PR: http://www.businesswire.com/news/home/20150925005332/en/ ) Asthma is the most common chronic childhood disease and the largest cause of hospitalization; over 500,000 admissions per year. Asthma can be effectively managed through symptom awareness and adherence to medication. Our vision is to shift families from panic to self-management by providing tools that increase awareness and adherence to improve disease management. CareTRx by Gecko is a simple device that is added to existing inhalers. It empowers children and their parents to better manage their asthma by monitoring medication use, providing reminders and increasing disease awareness. Gecko is going to revolutionize the way we think about controlling Asthma.